Akathisia and abnormal movements of the upper extremities with venlafaxine and methimazole.
Ng
Jean
J
Department of Internal Medicine, Kettering Medical Center, Kettering, OH 45429, USA.
Sansone
Randy A
RA
McDonald
Stephen
S
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000378:metabolism; D013956:Antithyroid Agents / Q000009:adverse effects*; D001132:Arm; D015984:Causality; D003511:Cyclohexanols / Q000009:adverse effects* / Q000378:metabolism; D019389:Cytochrome P-450 CYP2D6 / Q000187:drug effects; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D004347:Drug Interactions; D020820:Dyskinesias / Q000209:etiology*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008713:Methimazole / Q000009:adverse effects*; D008875:Middle Aged; D011595:Psychomotor Agitation / Q000209:etiology*; D011954:Receptors, Dopamine / Q000187:drug effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000378:metabolism; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D013956:Antithyroid Agents; D003511:Cyclohexanols; D019389:Cytochrome P-450 CYP2D6; D008713:Methimazole; D011954:Receptors, Dopamine; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride